Climb Bio Stock Forecast - Accumulation Distribution
| CLYM Stock | 5.12 0.35 7.34% |
Climb Stock outlook is based on your current time horizon. Although Climb Bio's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Climb Bio's systematic risk associated with finding meaningful patterns of Climb Bio fundamentals over time.
The RSI of Climb Bio's stock price is about 62 suggesting that the stock is rather overbought by investors as of now. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Climb, making its price go up or down. Momentum 62
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.81) | EPS Estimate Next Year (0.81) | Wall Street Target Price 9.5 | EPS Estimate Current Quarter (0.14) |
Using Climb Bio hype-based prediction, you can estimate the value of Climb Bio from the perspective of Climb Bio response to recently generated media hype and the effects of current headlines on its competitors.
Climb Bio after-hype prediction price | USD 5.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Climb Bio to cross-verify your projections. Climb Bio Additional Predictive Modules
Most predictive techniques to examine Climb price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Climb using various technical indicators. When you analyze Climb charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 74155.69 | 66218.1 |
| Check Climb Bio Volatility | Backtest Climb Bio | Information Ratio |
Climb Bio Trading Date Momentum
| On January 27 2026 Climb Bio was traded for 5.12 at the closing time. The top price for the day was 5.27 and the lowest listed price was 4.70 . The trading volume for the day was 612.2 K. The trading history from January 27, 2026 did not affect price variability. The overall trading delta against the current closing price is 7.23% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Climb Bio to competition |
Other Forecasting Options for Climb Bio
For every potential investor in Climb, whether a beginner or expert, Climb Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Climb Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Climb. Basic forecasting techniques help filter out the noise by identifying Climb Bio's price trends.Climb Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Climb Bio stock to make a market-neutral strategy. Peer analysis of Climb Bio could also be used in its relative valuation, which is a method of valuing Climb Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Climb Bio Market Strength Events
Market strength indicators help investors to evaluate how Climb Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Climb Bio shares will generate the highest return on investment. By undertsting and applying Climb Bio stock market strength indicators, traders can identify Climb Bio entry and exit signals to maximize returns.
Climb Bio Risk Indicators
The analysis of Climb Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Climb Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting climb stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.84 | |||
| Semi Deviation | 4.76 | |||
| Standard Deviation | 8.06 | |||
| Variance | 64.96 | |||
| Downside Variance | 30.69 | |||
| Semi Variance | 22.63 | |||
| Expected Short fall | (7.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Climb Bio
The number of cover stories for Climb Bio depends on current market conditions and Climb Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Climb Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Climb Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Climb Bio Short Properties
Climb Bio's future price predictability will typically decrease when Climb Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Climb Bio often depends not only on the future outlook of the potential Climb Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Climb Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.2 M | |
| Cash And Short Term Investments | 150.9 M |
Check out Historical Fundamental Analysis of Climb Bio to cross-verify your projections. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.